Chairman of the Board

Mr. Mackie is Chairman of bioLytical™ LABORATORIES Inc. His career in business spans more than 20 years; providing leadership and expertise to a number of companies. Mr. Mackie is experienced in import/export, business-to-business transactions, corporate takeover and restructuring, and marketing strategy. He was co-founder and owner of one of the largest mobile communications companies in Western Canada. For more than 10 years he has successfully managed land and commercial real estate within an international portfolio. Born and raised in British Columbia, Mr. Mackie is actively involved in a number of charitable organizations as well as fund raising for community sports and youth educational programs. He is an active contributor to the INSTI™ Foundation both at home and abroad.

President and Chief Executive Officer

Carl Roy is the Chief Executive Officer of bioLytical ™ LABORATORIES Inc. Mr. Roy has almost 25 years of health care leadership experience, across three Canadian provinces and was recently named one of the top 50 most powerful business executives in Vancouver. He was recognized for his ability to develop and execute a vision for facility redevelopment, substantially derived from quality relationships.

Mr. Roy comes to bioLytical™ Laboratories from Perceptronix Medical Inc. (‘Perceptronix’) where he served as President and Chief Executive Officer from September 2006. Under Mr. Roy’s leadership, Perceptronix successfully shifted its strategic focus from research and development to product commercialization.

Mr. Roy was previously President of Caritas Health Group in Edmonton, Alberta, operating four facilities in collaboration with the Capital Health Authority, a fully integrated academic health sciences centre. Prior to joining Caritas, he was President and Chief Executive Officer of Sudbury General Hospital and St. Joseph's Health Centre in Sudbury, Ontario.

Mr. Roy has a Master of Health Science Administration from the University of Toronto and is a Certified Health Executive (Canadian College of Health Service Executives).

Chief Science Officer

Dr. Michael  O'Shaughnessy is the Chief Science Officer at bioLytical ™ LABORATORIES Inc. Dr. O’Shaughnessy was hired as founding director of the B.C. Centre for Excellence in HIV/AIDS in 1992. In 2001, he was appointed Vice President of Research and Tertiary Programs at Providence Health Care, and Assistant Dean of Research in the Faculty of Medicine at the University of British Columbia. Under his leadership, the Centre has developed into a national and world leader in HIV/AIDS treatment and research. Dr. O’Shaughnessy retired as Director of the Centre in October 2003, but continues to be an opinion leader in HIV and health care issues.

Kyle Washington oversees the Washington Marine Group as Executive Chairman of the Board. After graduating from the University of Montana with a business finance degree, Mr. Washington moved to Vancouver, British Columbia. He started in a marketing position at a small marine ship berthing company called Cates Tugs. In 1997, Mr. Washington moved over to Seaspan International Ltd., where he was repositioned throughout the ranks. During this time, the company successfully completed and integrated many marine acquisitions and he and his new team grew the Washington Marine Group shipyards into the largest in Canada. In 2000, along with his two partners, he steered the company into the containership business. In just a few short years, the company became the fastest growing containership owner/operator in the world. Recently, the team ordered the largest containership in the world -- boasting a whopping 9,400 TEU's. bioLytical™ is honored to have one of Canada’s finest businessmen on board the team, and Kyle will no doubt help to steer bioLytical™'s vision of this incredible product in the world of HIV.

back to top